Medicamen Biotech Ltd is focusing on oncology therapeutics & other generics with a vision to be a Global Leader in Oncology generics by offering affordable medicine with best-in-class quality.
Apart from the above, a set of 10 Non-oncology formulations is also being determined in R & D for EU market filings. The company has firm plans & investments for Global rollout of its oncology Products in USA, Europe, Latin America, Asia-Pacific, MENA etc. through a combination of own team & alliance partners.
CMP - 712
Target - 1000, 1400, 2000, 2500+